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Abstract The effect of aging and acute treatment with acetyl-L- 
carnitine on the pyruvate transport and oxidation in rat heart 
mitochondria was studied. The activity of the pyruvate carrier as 
well as the rates of pyruvate-supported respiration were both 
depressed (around 40%) in heart mitochondria from aged rats, 
the major decrease occurring during the second year of life. 
Administration of acetyI-L-carnitine to aged rats almost 
completely restored the rates of these metabolic functions to 
the level of young control rats. This effect of acetyl-L-carnitine 
was not due to changes in the content of pyruvate carrier 
molecules. The heart mitochondrial content of cardiolipin, a key 
phospholipid necessary for mitochondrial substrate transport, 
was markedly reduced (approximately 40%) in aged rats. 
Treatment of aged rats with acetyl-L-carnitine reversed the 
age-associated decline in cardiolipin content. As the changes in 
cardiolipin content were correlated with changes in rates of 
pyruvate transport and oxidation, it is suggested that acetyl-L- 
carnitine reverses the age-related ecrement in the mitochondrial 
pyruvate metabolism by restoring the normal cardiolipin content. 
© 1999 Federation of European Biochemical Societies. 
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1. Introduction 
Aging is known to be associated with alterations of various 
aspects of the cell function. At  the cardiac level, aging causes 
a decline in functional competence. The molecular basis of 
this phenomenon is still not well understood. Mitochondr ia 
are considered to be a likely subcellular locus of this decline 
due to their central role in cardiac cell bioenergetics [1]. A 
crucial point in regulation of the mitochondrial  energy metab- 
olism is represented by the transport  of metabolites across the 
mitochondrial  inner membrane. Age-linked decrements in the 
activity of several anion transport ing systems present in heart 
mitochondria have been reported [2 5]. 
Pyruvate plays an essential role in the heart mitochondrial  
energy metabolism. The transport  of this substrate into mito- 
chondria is carrier-mediated [6,7]. More recently, the pyruvate 
carrier has been isolated and its activity reconstituted in lipo- 
somes. A requirement of cardiolipin for mitochondrial  pyru- 
vate translocase activity has been demonstrated [8]. 
A growing body of evidence suggests that the age-related 
deficit in the mitochondrial  function can be slowed or reversed 
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by acetyl-k-carnitine (ALCAR),  a normal component of the 
rnitochondrial membrane [9-12]. We have recently reported 
that the activity of several anion carrier proteins such as the 
phosphate [13], ADP/ATP  [14] and carnitine carriers [5] as 
well as that of cytochrome oxidase [14] is depressed in cardiac 
mitochondr ia from aged rats and that treatment of aged rats 
with ALCAR restored the activity of these membrane-bound 
proteins to the level of young control rats. Changes in the 
mitochondrial  cardiolipin content have been suggested to be 
responsible for this effect of ALCAR.  As the activity of the 
pyruvatc carrier appears to be cardiol ipin-dependent [8], we 
have examined the effect of aging and ALCAR treatment on 
the pyruvate translocase activity, on the pyruvate oxidation 
and on the cardiolipin content in rat heart mitochondria. 
2. Materials and methods 
Male Fisher rats of 5 months (young), 12 months (mature) and 28 
months (aged) were used for these studies. In each experiment, wo 
rats of each group were injected intraperitoneally with 300 mg/kg 
body weight ALCAR in NaC1 (0.9%) [13]. In the same way, control 
animals received only the solvent for the same period. 3 h after the 
injection, the rats were killed by decapitation. 
Rat heart mitochondria were prepared by differential centrifugation 
of heart homogenates a described previously [3]. 
Rat heart mitoplasts were prepared according to [15]. 
The mitochondrial protein concentration was determined by the 
usual biuret method using serum albumin as standard. 
The standard medium used in the measurements of pyruvate trans- 
port, respiratory activity and binding experiments usually contained 
100 mM sucrose, 50 mM KC1, 20 mM Tris-HCL 1 mM MgC12 and 
0.5 mM EDTA. 
The transport of pyruvate in mitochondria was measured by the 
inhibitor stop method, using c(-cyanocinnamate as inhibitor, essen- 
tially as described in [3]. Briefly, mitochondria (1 1.5 mg of protein) 
were pre-incubated in plastic centrifuge tubes at 10°C in a reaction 
medium described above in the presence of 0.5 gM sodium arsenite, 
5 gg/ml rotenone, 0.5 pg/ml antimycin, 3 mM ascorbic acid, 0.05 mM 
TMPD, final pH 7.4. After 3 min of pre-incubation, radiolabelled 
pyruvate was added and 30 s later, the reaction was stopped by the 
addition of 1 mM c~-cyanocinnamate. The tubes were rapidly centri- 
fuged and the mitochondrial pellet was solubilized and transferred to 
a scintillation counter. The amount of radiolabelled pyruvate, ex- 
pressed as nmol/mg mitochondrial protein, associated with the mito- 
chondria was calculated from the amount of radioactivity in the mi- 
tochondrial pellet and the specific activity of the [~4C]pyruvate. 
The content of pyruvate translocator was determined by titrating 
the amount of c(-cyano[14C]cinnamate bound to mitochondria as de- 
scribed in [16]. 
Mitochondrial respiratory parameters were measured at 25°C with 
approximately 0.8 1.2 mg protein in a 1.5 water-jacketed cell and 
oxygen consumption was measured with a Rank oxygen electrode. 
Phospholipids were analyzed by high-pressure liquid chromatogra- 
phy, using a Beckman 344 gradient liquid chromatograph. Extraction 
and analysis of phospholipids were carried out essentially as described 
in [17]. 
Results are expressed as mean+ S.E.M. Statistical significance was 
determined by Student's t-test. 
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Table 1 
The effect of aging and ALCAR treatment on the kinetic parameters of the pyruvate carrier in rat heart mitochondria 
Animals Km (gM) Vmax (nmol/min/mg protein) Change % 
Young 215 + 21 6.8 + 0.7 
Young+ALCAR 218 + 24 7.0 -+ 0.8 
Mature 222 + 19 6.5 + 0.9 
Mature+ALCAR 230 _+ 28 6.7 + 0.8 
Aged 231 + 23 4.1 + 0.5 b 
Aged+ALCAR 209 -+ 28 6.6 + 0.8 a 
40 
3 
The Km and Vmax values for pyruvate transport were calculated from double reciprocal plots of the rates of pyruvate uptake versus pyruvate 
concentrations (ranging from 0.05 to 1 mM) essentially as described in Section 2. Each value represents the mean+ S.E.M. for three separate 
experiments with two rats for each group. 
aControl versus treated, P < 0.01. 
bAged versus young, P < 0.05. 
3. Results 
The kinetic parameters of the pyruvate carrier in mitochon- 
dria isolated from young, mature and aged rats, pre-treated or 
not with ALCAR,  are presented in Table 1. While the affinity 
of the carrier for pyruvate was practically the same in all these 
mitochondrial  preparations, the maximal activity of this car- 
rier system was significantly depressed (40%) in mitochondria 
from aged rats when compared with that obtained in mito- 
chondria from young control rats. No appreciable change was 
observed in mitochondr ia isolated from mature rats. Treat- 
ment of aged rats with ALCAR almost completely restored 
the activity of the pyruvate carrier to the value of young rats. 
This compound had practically no effect on the activity of the 
pyruvate carrier in mitochondria isolated from young and 
mature rats. 
It has been demonstrated that the transport  of pyruvate in 
heart mitochondr ia is the rate-limiting step for pyruvate oxi- 
dation [18]. Thus, changes in the activity of pyruvate trans- 
port may be associated with parallel changes in the rates of 
pyruvate-dependent oxygen utilization. Results of experiments 
on pyruvate oxidation in heart mitochondr ia isolated from 
young, mature and aged rats, pre-treated or not with 
ALCAR,  are presented in Table 2. Rates of phosphorylat ing 
oxygen consumption with pyruvate were significantly de- 
pressed (38%) in mitochondr ia from aged rats, whereas they 
were the same in mitochondria isolated from mature rats 
Table 2 
The effect of aging and ALCAR treatment on the 
supported respiration in rat heart mitochondria 
rates of pyruvate- 
Animals Rates of oxygen consumption ( g atoms 
O/min/mg protein) 
State 3 State 4 RCR 
Young 282 _+ 27 35.5 + 3.5 7.94 
Young+ALCAR 286 -+ 28 36.2 + 3.7 7.90 
Mature 272 + 24 32.4 + 3.1 8.39 
Mature+ALCAR 281 _+ 26 34.7 + 2.9 8.11 
Aged 176 + 2 l 28.2 _+ 3.1 b 6.24 
Aged+ALCAR 278 + 25 34.8 _+ 3.8 a 7.98 
The pyruvate-dependent oxygen uptake was measured as described 
in Section 2. Mitochondria (0.8 1.2 mg protein/ml) were pre-incu- 
bated in the standard reaction medium described above. Final pH 
7.2, 25°C. When a steady state of oxygen consumption was ob- 
tained, 0.5 mM pyruvate and 2 mM malate were added. 1 min later, 
respiration was stimulated by the addition of 2 mM ADP. Each val- 
ue represents the mean + S.E.M. for three separate xperiments with 
two rats for each group. 
aControl versus treated, P < 0.01. 
bAged versus young, P < 0.05. 
when compared to the values of young control rats. Treat- 
ment of aged rats with ALCAR restored the rates of pyruvate 
oxygen consumption to the level of young rats. 
The ability of ALCAR to reverse the altered pyruvate car- 
rier activity in mitochondr ia from aged rats could be due to 
an increase in the pyruvate carrier level. To test this possibil- 
ity, the pyruvate carrier molecules were titrated by following 
the binding of radiolabelled c~-cyanocinnamate to mitochon- 
dria. The total number  of c~-cyanocinnamate binding sites to 
mitochondria can be taken as quantitative xpression of the 
number  of pyruvate carrier molecules [16]. No change was 
found in the level of pyruvate carrier molecules in mitochon- 
dria isolated from young and aged rats pre-treated or not with 
ALCAR (a value around 48 pmol/mg protein of c~-cyanocin- 
namate binding sites was obtained for all these preparations 
of mitochondria). 
It has been reported that cardiolipin, a phosphol ipid lo- 
cated in the inner mitochondrial  membrane, is required for 
the functioning of the isolated pyruvate carrier reconstituted 
in liposomes [8]. Thus, changes in the mitochondrial  cardioli- 
pin content may be responsible for the observed changes in 
the pyruvate carrier activity with age. As the pyruvate carrier 
protein is located at the level of the inner mitochondrial  mem- 
brane, the phospholipid composit ion of mitoplasts isolated 
from young and aged rats, pre-treated or not with ALCAR,  
was analyzed. The results reported in Table 3 show that the 
level of cardiolipin was significantly reduced (39%) in mito- 
plasts from aged rats when compared to the value of young 
control rats. ALCAR administrat ion to aged rats reversed this 
loss in cardiolipin concentrat ion to a level not significantly 
different from young animals. Similar results have recently 
been reported by Hagen and colleagues with hepatocytes i o- 
lated from old rats supplemented with ALCAR [12]. No effect 
was observed on the concentrat ion of other mitochondrial  
phospholipids. 
4. Discussion 
The observations of this study are consistent with a pre- 
vious report showing that the cardiac mitochondrial  pyruvate 
metabol ism is depressed in aged animals [3]. In fact, it is 
shown here that the activity of the pyruvate carrier and the 
rates of pyruvate-supported oxygen consumption are both de- 
pressed in heart mitochondria from aged rats, the major de- 
crease occurring during the second year of life. Administra- 
tion of ALCAR to aged rats almost completely restored the 
rates of these metabolic functions to the level of young control 
rats. 
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Table 3 
The effect of aging and ALCAR treatment on the phospholipid composition in rat heart mitoplasts 
209 
Phospholipid Distribution(mol%) 
Young Young+ALCAR Aged Aged+ALCAR 
DPG 22.4±1.8 22.8±2.1 13.7k1.1 b 22.1±1.6 b 
PE 35.6±2.7 35.0±3.1 39.8±2.2 35.9±2.1 
PC 40.4±2.9 40.6±3.6 44.4±3.7 40.2±3.1 
PI 0.4±0.06 0.4±0.06 0.6±0.08 0.6±0.08 
PS 1.220.2 1.2±0.1 1.5±0.5 1.2±0.2 
For phospholipids extraction andanalysis, see Section 2. Each value represents the mean + S.E.M. of three experiments with two rats of each 
group. DPG, cardiolipin; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol; PS, phosphatidylserine. 
aControl versus treated, P < 0.01. 
bAged versus young, P < 0.05. 
An increase in pyruvate carrier protein levels might repre- 
sent one mechanism by which ALCAR reverses the aged-re- 
lated decline in pyruvate carrier activity. However, this possi- 
bility appears to be unlikely in that no change was found in 
the level of pyruvate carrier molecules in mitochondria iso- 
lated from aged rats treated with ALCAR. 
Restoration of the correct lipid environment of the pyruvate 
carrier molecules in the inner mitochondrial membrane may 
represent a plausible mechanism by which ALCAR reverses 
the altered pyruvate carrier activity with age. In fact, it has 
been reported that cardiolipin, a phospholipid almost exclu- 
sively associated with the inner mitochondrial membrane, is
required for the functioning of the isolated pyruvate carrier 
reconstituted in liposomes [8]. In addition, we have previously 
reported that the transport of pyruvate in mitochondria is 
inhibited by doxorubicin [19], an anti-tumoral agent which 
is known to form a specific complex with cardiolipin [20]. 
Thus, changes in the mitochondrial cardiolipin level may af- 
fect the activity of the pyruvate carrier in vivo. Our results 
demonstrate that the cardiolipin content is markedly reduced 
in mitoplasts from aged rats as compared with control young 
rats. This reduced level of cardiolipin is brought back to the 
level of young rats by treatment of aged rats with ALCAR. 
These changes in the cardiolipin level are quantitatively asso- 
ciated with parallel changes in the rates of pyruvate transport 
and oxidation. Thus, it is conceivable that the restoration of 
the pyruvate metabolism in heart mitochondria from aged rats 
by ALCAR may depend upon the ability of this compound to 
restore the correct level of cardiolipin, which is needed for 
functioning of the pyruvate carrier. It should be noted that 
administration of ALCAR to young and mature rats had 
practically no effect either on the level of cardiolipin or on 
the activity of the mitochondrial pyruvate carrier and pyru- 
vate oxidation. This suggests that the observed effects of AL- 
CAR are related to changes produced by aging. 
The results reported do not provide evidence on the molec- 
ular mechanism by which ALCAR restores the normal cardi- 
olipin content in cardiac mitochondria from aged rats. One 
possibility is that ALCAR may influence the activity of car- 
diolipin synthase, the enzyme protein responsible for the bio- 
synthesis of cardiolipin, as recently suggested for the effect of 
thyroxin on the activity of this enzyme in rat liver mitochon- 
dria [21,22]. 
Pyruvate, together with free fatty acids, is the major energy 
source for the heart tissue. Therefore, the observed effect of 
ALCAR on the mitochondrial level of cardiolipin and thereby 
on the activity of pyruvate carrier (present results) as well as 
on that of other substrate transport proteins [5,13,14] and on 
the cytochrome oxidase activity [14] may explain, at least in 
part, the stimulatory effect of this compound on the cardiac 
energy metabolism of aged animals. 
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